SGHT Sight Sciences, Inc.

Sight Sciences Inc is a growth-stage medical device company transforming the two fastest growing segments in ophthalmology and optometry, glaucoma and dry eye disease. The company's product portfolio features the OMNI Surgical System, a dually-indicated device that facilitates the performance of both trabeculotomy and viscoelastic delivery. The company's non-surgical product portfolio consists of TearCare system which is commercially available for both ophthalmologists and optometrists.

$20.68  -0.82 (-3.81%)
As of 12/03/2021 12:22:27 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  USA
IPO date:  07/15/2021
Outstanding shares:  47,307,477
Average volume:  247,504
Market cap:   $953,718,736
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    82657M105
ISIN:        US82657M1053
Sedol:      BN2T5Q6
Valuation   (See tab for details)
PE ratio:   -21.63
PB ratio:   4.13
PS ratio:   22.05
Return on equity:   -22.82%
Net income %:   -129.74%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy